Clinical Trials Browser

Active not recruiting × Neurotoxicity Syndromes × 1 year × Clear all

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Phase EARLY_PHASE1 Active not recruiting

37 enrolled

Lymphoid

Lymphoma, Neurotoxicity Syndromes

NCT03696784 2025-12-08

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

Phase 1 Active not recruiting

19 enrolled

Lymphoid

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT05025826 2025-12-02

PROPERTY

Phase NA Active not recruiting

110 enrolled

Gastrointestinal

Stomach Neoplasms, Neurotoxicity Syndromes

NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Phase 3 Active not recruiting

540 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Clinical Trials

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

PROPERTY

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma